Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: Case-control study

The University of Edinburgh, Edinburgh, Scotland, United Kingdom
Journal of Allergy and Clinical Immunology (Impact Factor: 11.48). 09/2007; 120(2):381-7. DOI: 10.1016/j.jaci.2007.03.034
Source: PubMed


Seasonal allergic rhinitis is common globally, and symptoms have been shown to impair learning ability in children in laboratory conditions. Critical examinations in children are often held in the summer during the peak grass pollen season.
To investigate whether seasonal allergic rhinitis adversely impacts examination performance in United Kingdom teenagers.
Case-control analysis of 1,834 students (age 15-17 years; 50% girls) sitting for national examinations. Cases were those who dropped 1 or more grades in any of 3 core subjects (mathematics, English, and science) between practice (winter) and final (summer) examinations; controls were those whose grades were either unchanged or improved. Associations between allergic rhinitis symptoms, clinician-diagnosed allergic rhinitis, and allergic rhinitis-related medication use, recorded on examination days immediately before the examination, were assessed using multilevel regression models.
Between 38% and 43% of students reported symptoms of seasonal allergic rhinitis on any 1 of the examination days. There were 662 cases (36% of students) and 1,172 controls. After adjustment, cases were significantly more likely than controls to have had allergic rhinitis symptoms during the examination period (odds ratio [OR], 1.4; 95% CI, 1.1-1.8; P = .002), to have taken any allergic rhinitis medication (OR, 1.4; 95% CI, 1.1-1.7; P = .01), or to have taken sedating antihistamines (OR, 1.7; 95% CI, 1.1-2.8; P = .03).
Current symptomatic allergic rhinitis and rhinitis medication use are associated with a significantly increased risk of unexpectedly dropping a grade in summer examinations.
This is the first time the relationship between symptomatic allergic rhinitis and poor examination performance has been demonstrated, which has significant implications for clinical practice.

17 Reads
    • "Chez l'enfant, il s'agit des deux maladies non transmissibles les plus courantes et la cause la plus fréquente de visites dans les services d'urgence et des admissions à l'hôpital. Ces pathologies infantiles ont des conséquences certaines sur la vie scolaire et sociale [4]. En ce qui concerne les allergies alimentaires, les allergies graves présentant un risque de crise aiguë ou de réactions anaphylactiques potentiellement mortelles, c'est 17 millions d'européens qui sont concernés. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Health devices in France and abroad are crossed by strong tensions. Causes are multiple: demography of health professionals strained, non-communicable and chronic diseases on the rise. The need to develop ways of more efficient innovative taken loads becomes a priority. The field of allergology is affected by these tensions in several respects: a steady increase in the prevalence of allergic diseases, necessary training of specialists that can handle complex situations and develop research, organization of new health system, combining hospital medicine and territory. Skills mix between health professionals are already implemented in some medical specialties, as a response to the health needs of populations in the country and especially in medical emptiness. The practice of nursing in allergology requires skills not acquired by the initial degree nursing expertise (bachelor). Nurses practicing in allergy can contribute to device health, when they received solid academic training and background, in support of a strong field experience. The authors analyze advanced practice training in different countries and propose a training program for master level in response to the needs of quality of care and patient safety in this area.
    Revue Française d'Allergologie 11/2014; 55(1). DOI:10.1016/j.reval.2014.09.003 · 0.25 Impact Factor
  • Source
    • "AR is clinically defined by the presence of rhinorrhea, nasal obstruction, nasal itching, and sneezing which are reversible spontaneously or with treatment [2]. Rhinitis affects quality of life, performance and attendance at school [3], and work. It has significant impact on healthcare costs [4]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Allergic rhinitis is a global health problem that is often treated with homeopathy. The objective of this review will be to evaluate the effectiveness of homeopathic treatment of allergic rhinitis. Methods/Design The authors will conduct a systematic review. We will search Medline, CENTRAL, CINAHL, EMBASE, AMED, CAM-Quest, Google Scholar and reference lists of identified studies up to December 2013. The review will include randomized controlled trials that evaluate homeopathic treatment of allergic rhinitis. Studies with participants of all ages, with acute or chronic comorbidities will be included. Patients with immunodeficiency will not be included. The diagnosis will be based on the published guidelines of diagnosis and classification. Studies of all homeopathy modalities (clinical, complex and classical homeopathy, and isopathy) will be included. We will include trials with both active controls (conventional therapy, standard care) and placebo controls. The primary outcomes are: an improvement of global symptoms recorded in validated daily or weekly diaries and any scores from validated visual analogue scales; the total Quality of Life Score (such as the Juniper RQLQ);individual symptoms scores which include any appropriate measures of nasal obstruction, runny nose, sneezing, itching, and eye symptoms; and number of days requiring medication. Secondary outcomes selected will include serum immunoglobin E (IgE) levels, individual ocular symptoms, adverse events, and the use of rescue medication. Treatment effects will be measured by calculating the mean difference and the standardized mean difference with 95% confidence interval (CI) for continuous data. Risk ratio or, if feasible, odds ratio will be calculated with 95% CI for dichotomous data. After assessing clinical and statistical heterogeneity, meta-analysis will be performed, if appropriate. The individual participant will be the unit of analysis. Descriptive information on missing data will be included about participants missing due to drop out, whether there was intention to treat or per protocol analysis and missing statistics. A number of subgroups, homeopathic potency, age groups, and types of allergic rhinitis (seasonal or perennial) will be analyzed. Sensitivity analysis will be performed to explore the impact of risk of bias on overall treatment effect. Systematic review registration PROSPERO CRD42013006741
    Systematic Reviews 06/2014; 3(1):59. DOI:10.1186/2046-4053-3-59
  • Source
    • "Allergic rhinitis is a long-term condition with a high prevalence (estimated at 26% in the UK [1]) that has increased substantially in recent years [2]. Allergic rhinitis has a significant negative impact on quality of life (QOL) [3], productivity [4], school performance [5] and health care costs [6,7]. Co-morbidity of allergic rhinitis with asthma is common and is associated with poor asthma outcomes [8-10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the availability of evidence-based guidelines for managing allergic rhinitis in primary care, management of the condition in the United Kingdom (UK) remains sub-optimal. Its high prevalence and negative effects on quality of life, school performance, productivity and co-morbid respiratory conditions (in particular, asthma), and high health and societal costs, make this a priority for developing novel models of care. Recent Australian research demonstrated the potential of a community pharmacy-based 'goal-focused' intervention to help people with intermittent allergic rhinitis to self-manage their condition better, reduce symptom severity and improve quality of life. In this pilot study we will assess the transferability of the goal-focused intervention to a UK context, the suitability of the intervention materials, procedures and outcome measures and collect data to inform a future definitive UK randomized controlled trial (RCT). A pilot cluster RCT with associated preliminary economic analysis and embedded qualitative evaluation. The pilot trial will take place in two Scottish Health Board areas: Grampian and Greater Glasgow & Clyde. Twelve community pharmacies will be randomly assigned to intervention or usual care group. Each will recruit 12 customers seeking advice or treatment for intermittent allergic rhinitis. Pharmacy staff in intervention pharmacies will support recruited customers in developing strategies for setting and achieving goals that aim to avoid/minimize triggers for, and eliminate/minimize symptoms of allergic rhinitis. Customers recruited in non-intervention pharmacies will receive usual care. The co-primary outcome measures, selected to inform a sample size calculation for a future RCT, are: community pharmacy and customer recruitment and completion rates; and effect size of change in the validated mini-Rhinoconjunctivitis Quality of Life Questionnaire between baseline, one-week and six-weeks post-intervention. Secondary outcome measures relate to changes in symptom severity, productivity, medication adherence and self-efficacy. Quantitative data about accrual, retention and economic measures, and qualitative data about participants' experiences during the trial will be collected to inform the future RCT. This work will lay the foundations for a definitive RCT of a community pharmacy-based 'goal-focused' self-management intervention for people with intermittent allergic rhinitis. Results of the pilot trial are expected to be available in April 2013.Trial registration: Current Controlled Trials ISRCTN43606442.
    Trials 07/2013; 14(1):217. DOI:10.1186/1745-6215-14-217 · 1.73 Impact Factor
Show more